JP2021521201A5 - - Google Patents

Info

Publication number
JP2021521201A5
JP2021521201A5 JP2020555884A JP2020555884A JP2021521201A5 JP 2021521201 A5 JP2021521201 A5 JP 2021521201A5 JP 2020555884 A JP2020555884 A JP 2020555884A JP 2020555884 A JP2020555884 A JP 2020555884A JP 2021521201 A5 JP2021521201 A5 JP 2021521201A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
seq
bst1
chain variable
Prior art date
Application number
JP2020555884A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019197609A5 (https=
JP2021521201A (ja
Filing date
Publication date
Priority claimed from GBGB1806084.8A external-priority patent/GB201806084D0/en
Application filed filed Critical
Publication of JP2021521201A publication Critical patent/JP2021521201A/ja
Publication of JPWO2019197609A5 publication Critical patent/JPWO2019197609A5/ja
Publication of JP2021521201A5 publication Critical patent/JP2021521201A5/ja
Withdrawn legal-status Critical Current

Links

JP2020555884A 2018-04-13 2019-04-12 骨髄異形成症候群を予防または治療するためのｂｓｔ１に対する抗体 Withdrawn JP2021521201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1806084.8A GB201806084D0 (en) 2018-04-13 2018-04-13 Antibodies
GB1806084.8 2018-04-13
PCT/EP2019/059420 WO2019197609A1 (en) 2018-04-13 2019-04-12 Antibodies against bst1 for preventing or treating myelodysplastic syndrome

Publications (3)

Publication Number Publication Date
JP2021521201A JP2021521201A (ja) 2021-08-26
JPWO2019197609A5 JPWO2019197609A5 (https=) 2022-04-19
JP2021521201A5 true JP2021521201A5 (https=) 2022-04-19

Family

ID=62203296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020555884A Withdrawn JP2021521201A (ja) 2018-04-13 2019-04-12 骨髄異形成症候群を予防または治療するためのｂｓｔ１に対する抗体

Country Status (7)

Country Link
US (1) US20210032360A1 (https=)
EP (1) EP3773917A1 (https=)
JP (1) JP2021521201A (https=)
CN (1) CN111971091A (https=)
GB (1) GB201806084D0 (https=)
TW (1) TW201943732A (https=)
WO (1) WO2019197609A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201711785D0 (en) * 2017-07-21 2017-09-06 Berlin-Chemie Ag Antibodies
CN112630438B (zh) * 2021-03-08 2021-06-22 信纳克(北京)生化标志物检测医学研究有限责任公司 抗体组合物及其筛查髓系疾病及检测免疫检查点的应用
CN119301155A (zh) * 2022-07-19 2025-01-10 百进生物科技公司 抗cd157抗体、其抗原结合片段和组合物及其制备和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005295921A (ja) * 2004-04-14 2005-10-27 Pharma Design Inc 新規ｂｓｔ１選択的スプライシング変異体及びその用途
UA112062C2 (uk) * 2010-10-04 2016-07-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Cd33-зв'язувальний агент
UA114478C2 (uk) * 2011-06-28 2017-06-26 Берлін-Хемі Аг Антитіло, яке специфічно зв'язується з bst1

Similar Documents

Publication Publication Date Title
US20210024635A1 (en) Anti-wt1/hla-specific antibodies
JP2021514664A5 (https=)
JP2021524244A5 (https=)
JP2021527431A5 (https=)
JP2021524256A5 (https=)
IL276830B2 (en) Anti-claudin 18.2 antibodies and uses thereof
JP2021514973A5 (https=)
JPWO2019224711A5 (https=)
RU2018119165A (ru) Антитело против лиганда 1 запрограммированной гибели клеток (pd-l1), его антигенсвязывающий фрагмент и их медицинское применение
RU2016137110A (ru) Антитела к компоненту комплемента с5
RU2009120052A (ru) Композиции и способы связывания сфингозин-1-фосфата
RU2010132956A (ru) Ангиопоэтин-2-специфические связывающие агенты
CN111278861A (zh) Pd-l1抗体、其抗原结合片段及医药用途
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
JP2020522280A5 (https=)
JP2020522281A5 (https=)
JP2024016024A5 (https=)
JP2024024114A5 (https=)
CN111712521A (zh) Cd38蛋白抗体及其应用
IL250289B2 (en) Antibodies against angiopoietin-like 4 and methods of use
JP2021521201A5 (https=)
IL277899B2 (en) Methods and preparations for treating yellow fever
JPWO2020227457A5 (https=)
JPWO2020234399A5 (https=)
JPWO2019197609A5 (https=)